INDmoney
CRNX
Crinetics Pharmaceuticals Inc Earnings
$41.1
Earnings Summary
Revenue | $3.89Mn |
Net Profits | $-122.82Mn |
Net Profit Margins | -3161.26% |
Crinetics Pharmaceuticals Inc’s revenue jumped +Inf% since last year same period to $3.89Mn in the Q4 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated 2616.78% jump in its revenue since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit fell -52.39% since last year same period to $-122.82Mn in the Q4 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated 5.59% jump in its net profits since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -3161.26% in the Q4 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated 96.53% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.28 |
EPS Estimate Current Year | -1.28 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.28 - a -2.4% fall from last quarter’s estimates.
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.28.
Key Ratios
Earning Per Share (EPS) | -1.29 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) fell -46.59% since last year same period to -1.29 in the Q4 2025. This indicates that the Crinetics Pharmaceuticals Inc has generated -46.59% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-06 | -1.25 | -1.38 | -10.4% |
2026-02-26 | -1.28 | -1.29 | -0.78% |
2025-08-07 | -1.1 | -1.23 | -11.82% |
2025-05-08 | -0.95 | -1.04 | -9.21% |
